Order Article Reprints

Shvartz V, Khugaeva E, Kryukov Y, Sokolskaya M, Ispiryan A, Shvartz E, Petrosyan A, Dorokhina E, Bockeria L, Bockeria O. Long-Term Preoperative Atorvastatin or Rosuvastatin Use in Adult Patients before CABG Does Not Increase Incidence of Postoperative Acute Kidney Injury: A Propensity Score-Matched Analysis. Pathophysiology. 2022; 29(3):354-364. https://doi.org/10.3390/pathophysiology29030027

Shvartz, Vladimir, Eleonora Khugaeva, Yuri Kryukov, Maria Sokolskaya, Artak Ispiryan, Elena Shvartz, Andrey Petrosyan, Elizaveta Dorokhina, Leo Bockeria, and Olga Bockeria. 2022. "Long-Term Preoperative Atorvastatin or Rosuvastatin Use in Adult Patients before CABG Does Not Increase Incidence of Postoperative Acute Kidney Injury: A Propensity Score-Matched Analysis" Pathophysiology 29, no. 3: 354-364. https://doi.org/10.3390/pathophysiology29030027

Shvartz, V., Khugaeva, E., Kryukov, Y., Sokolskaya, M., Ispiryan, A., Shvartz, E., Petrosyan, A., Dorokhina, E., Bockeria, L., & Bockeria, O. (2022). Long-Term Preoperative Atorvastatin or Rosuvastatin Use in Adult Patients before CABG Does Not Increase Incidence of Postoperative Acute Kidney Injury: A Propensity Score-Matched Analysis. Pathophysiology, 29(3), 354-364. https://doi.org/10.3390/pathophysiology29030027